Status:
WITHDRAWN
A Prospective, Observational Study of the PPI Non-responder
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Gastro Esophageal Reflux Disease PPI Non-Responders
Eligibility:
All Genders
18+ years
Brief Summary
Gastroesophageal reflux disease (GERD) is a common chronic condition, affecting approximately 20% of the American adult population. Proton pump inhibitors (PPIs) are now the mainstay of medical therap...
Detailed Description
Gastroesophageal reflux disease (GERD) is a common chronic condition, affecting approximately 20% of the American adult population. Gastroesophageal reflux disease is characterized by a number of symp...
Eligibility Criteria
Inclusion
- Willing and able to sign informed consent
- Persistent GERD symptoms after minimum 8 week trial on daily PPI
Exclusion
- Unwilling to sign informed consent
- Prior anti-reflux surgery
Key Trial Info
Start Date :
June 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03282084
Start Date
June 20 2017
End Date
June 15 2018
Last Update
April 2 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.